SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-14489"
 

Search: onr:"swepub:oai:DiVA.org:liu-14489" > Plasma S/R ratio of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Osman, AbdimajidÖstergötlands Läns Landsting,Linköpings universitet,Klinisk kemi,Hälsouniversitetet (author)

Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype

  • Article/chapterEnglish2007

Publisher, publication year, extent ...

  • 2007
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-14489
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-14489URI
  • https://doi.org/10.1097/MBC.0b013e3280444bfdDOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • We recently reported that the low-dose VKORC1*2 haplotype is an important genetic determinant for warfarin dose requirement and is associated with difficulties to attain stable therapeutic prothrombin time-International Normalized Ratio in patients undergoing anticoagulation therapy. The aim of this study was to investigate whether patients with VKORC1*2 compared with patients carrying high-dose haplotypes VKORC1*3 or VKORC1*4 had different warfarin S/R ratios in their plasma, and whether that was related to CYP2C9 variants CYP2C9*2 and CYP2C9*3 or other factors. Samples from patients previously haplotyped for VKORC1 and measured for plasma warfarin concentration were genotyped for the CYP2C9 variants CYP2C9*2 and CYP2C9*3. Nonparametric statistical analysis was performed to elucidate whether there was any significant difference in the warfarin S/R ratio between the two patient groups. Our result shows that there is a significant difference (P < 0.01) in warfarin S/R ratios between VKORC1*2 and VKORC1*3 or VKORC1*4 patients. This difference did not originate from CYP2C9 variants CYP2C9*2 and CYP2C9*3. We speculate that VKORC1 haplotypes possibly are linked to some unidentified factors involved in the metabolic clearance of warfarin enantiomers. Dose-dependent variations in (S)-warfarin and (R)-warfarin clearance in these patients can also be a probable explanation for the difference in warfarin S/R ratios.

Subject headings and genre

  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Enström, CamillaLinköpings universitet,Institutionen för biomedicin och kirurgi,Hälsouniversitetet(Swepub:liu)camen30 (author)
  • Lindahl, TomasÖstergötlands Läns Landsting,Linköpings universitet,Klinisk kemi,Hälsouniversitetet(Swepub:liu)tomli13 (author)
  • Linköpings universitetKlinisk kemi (creator_code:org_t)

Related titles

  • In:Blood Coagulation and Fibrinolysis18:3, s. 293-2960957-52351473-5733

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Osman, Abdimajid
Enström, Camilla
Lindahl, Tomas
Articles in the publication
Blood Coagulatio ...
By the university
Linköping University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view